Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Shorts to cover

<< Previous

Bullboard Posts

Next >>

Post by Golddetectoron Nov 02, 2021 10:20am

120 Views

Post# 34076866

Shorts to cover

I expect to see some short covering here. Sp below 25cents is stupid cheap. The downturn in mj stocks played a role to bring it here. We can say it is pharma not mj but most of etf buying this are mj and ppl take it as such. Getting Reduvo will change how ppl look at this. Hopefully November will be the month. We still have all other major catalysts for QIXLEEF that are big items. Gl guys

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo